Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Treeline Biosciences

Request full access

Aspires to build transformative precision medicines for patients with cancer and other serious conditions

Stamford, United StatesFounded 2021Biotech & Life Sciences

About Treeline Biosciences

Treeline.bio is a biotechnology startup focused on discovering and developing new treatments for cancer and other serious diseases. The company operates in the healthcare and pharmaceutical market, targeting both patients and healthcare providers as its primary clients. Treeline.bio's business model revolves around extensive research and development (R&D) in the fields of biology, chemistry, protein sciences, and computational science to create innovative drug therapies.

The company generates revenue by developing proprietary drugs and therapies, which can then be licensed to larger pharmaceutical companies or sold directly to healthcare providers. Treeline.bio also collaborates with Contract Research Organizations (CROs) to enhance its research capabilities and expedite the drug discovery process. This approach allows the company to work on both long-term projects and near-term opportunities, ensuring a steady pipeline of potential treatments.

Recently, Treeline.bio secured significant funding from KKR's Health Care Strategic Growth Fund II. This financial backing provides the company with the resources needed to scale its operations, invest in long-term projects, and explore new scientific avenues. The funding also allows Treeline.bio to maintain a balanced internal R&D team and a robust intellectual property (IP) strategy, which are crucial for sustaining innovation and protecting its discoveries.

Treeline.bio's team comprises both seasoned biotech veterans and new talent, all committed to long-term projects. This diverse team structure fosters a culture of dedication and innovation, which is essential for the company's success in the competitive biotech industry.

Source: Dealroom company data

Treeline Biosciences in the Stamford ecosystem

Live from Dealroom

The Treeline Biosciences office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

13 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A13 investors entered at this stage

Employees mapped 169 incl. 3 AI specialists
Founders Hidden — book a demo/100 quality score
Key operators 10 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Patents

Estimated portfolio value
$379k

20 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

See Treeline Biosciences on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.